Metastatic Renal Cell Carcinoma: A Meta‑Analysis Review of Therapy Background In 2021, there will be an estimated 76,080 new cases of kidney cancer in the US (48,780 in men and 27,300 in women) and about 13,780 patients (4,990 women, 8,790 men) will die from this disease. The most common form of kidney
Optic 3D Modeling in Ophthalmic Treatment
Optic 3D Modeling in Ophthalmic Treatment Visual impairment is a global health concern. Visually impaired patients are at high risk for accidents, depression, and social withdrawal. Eye disorders like age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and retinitis pigmentosa (RP) cause irreparable vision loss and affect the quality of life of
iStent Combination Therapy for Glaucoma and Cataracts
iStent Combination Therapy for Glaucoma and Cataracts Considering that glaucoma is the most common cause of irreversible vision loss and the third most common cause of vision loss worldwide, with cataracts and refractive error being the most prevalent causes, iStent combination therapy to treat glaucoma and cataracts has high therapeutic value.
Second Primary Malignancies of Eye and Ocular Adnexa
Second Primary Malignancies of Eye and Ocular Adnexa Cancer found in the eye is a significant cause of death and disability around the world. Tumors of the eye and ocular adnexa are some of the most challenging cases that can lead to blindness or death. The eye and its ocular adnexa
Thermography in clinical ophthalmic oncology
THERMOGRAPHY AS A SCREENING TOOL IN CLINICAL OPHTHALMIC ONCOLOGY STUDY BACKGROUND Although intraocular tumors are rare, with an incidence of 5 per million adults, the diagnosis has been biased towards the physical examination, Color Doppler Imaging (CDI), Optical Coherence Tomography (OCT), Indocyanine Green Angiography (ICGA), or Fluorescein Angiography (FA). Literature reviews suggest
Combination IOP Reduction Therapy in Open-Angle Glaucoma
Combination IOP Reduction Therapy in Open-Angle Glaucoma GLAUCOMA BACKGROUND Globally, glaucoma is a leading cause of permanent blindness. As of 2020, about 80 million people worldwide, and 3 million Americans, are affected by glaucoma. The most common form of glaucoma is open-angle glaucoma. Unfortunately, the primary risk factor for open-angle glaucoma is
Stroke in the Presence of Renal Disease
Stroke in the Presence of Renal Disease Stroke is a life-threatening medical condition that occurs when blood supply to the part of the brain is cut off. It is one of the leading causes of death and disability around the world. Most strokes are caused by blockage of arteries to the
Technology-assisted methadone take-home dosing for patients with opioid use disorder
Technology-assisted methadone take-home dosing for patients with opioid use disorder Methadone maintenance treatment (MMT) is the most prevalent and effective treatment for opioid dependence. Sometimes, ‘take home’ privileges are offered to patients with Opioid Use Disorder (OUD); however, it is limited to the patients with regular clinical and counseling attendance, and
Can Sotagliflozin Prevent Cardiovascular Ailments for Patients with Diabetes and Chronic Kidney Disease?
Can Sotagliflozin Prevent Cardiovascular Ailments for Patients with Diabetes and Chronic Kidney Disease Cardiovascular diseases, including stroke, are major healthcare issues affecting humans worldwide. Between 2010 and 2030, the estimated total medical costs might escalate to from $273–$818 billion in the United States alone. Modifiable risk factors for stroke include hypertension, diabetes,
Involvement of Ocular Surface in Graft‐Versus‐Host Disease: A Review
Involvement of Ocular Surface in Graft-Versus-Host Disease: A Review Hematopoietic stem cell transplantation (HSCT) is a promising curative therapy for hematologic malignancies and other disorders of blood and bone marrow. Historically, HSCT was referred to as bone marrow transplantation (BMT) because bone marrow was the sole source of transplanted hematopoietic stem
